Immatics NV (IMTX)
8.69
-0.24
(-2.69%)
USD |
NASDAQ |
Aug 24, 16:00
8.70
+0.01
(+0.12%)
After-Hours: 20:00
Immatics Shareholders Equity (Quarterly) : 456.89M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 456.89M |
| March 31, 2026 | 525.17M |
| December 31, 2025 | 568.55M |
| September 30, 2025 | 489.60M |
| June 30, 2025 | 545.34M |
| March 31, 2025 | 579.64M |
| December 31, 2024 | 595.25M |
| September 30, 2024 | 426.92M |
| June 30, 2024 | 415.72M |
| March 31, 2024 | 432.85M |
| December 31, 2023 | 248.64M |
| September 30, 2023 | 262.31M |
| June 30, 2023 | 238.07M |
| March 31, 2023 | 217.38M |
| Date | Value |
|---|---|
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 130.62M |
| March 31, 2022 | 129.05M |
| December 31, 2021 | 27.36M |
| September 30, 2021 | 40.75M |
| June 30, 2021 | 90.65M |
| March 31, 2021 | 110.11M |
| December 31, 2020 | 106.92M |
| September 30, 2020 | 142.66M |
| June 30, 2020 | -76.93M |
| March 31, 2020 | -55.76M |
| December 31, 2019 | -46.98M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| MediGene AG | -- |
| InflaRx NV | 167.13M |
| BioNTech SE | 20.30B |
| Moderna, Inc. | 6.761B |
| Intellia Therapeutics, Inc. | 727.71M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 555.34M |
| Total Liabilities (Quarterly) | 98.45M |
| Debt to Equity Ratio | 0.0365 |
| Current Ratio | 7.536 |
| Net Debt Paydown Yield | 0.05% |